Liquid Biopsy as a Follow‐up Tool: Comment on Longitudinal Monitoring of Somatic Genetic Alterations in Circulating Cell‐free DNA During Treatment With Epidermal Growth Factor Receptor–tyrosine Kinase Inhibitors
Cancer - United States
doi 10.1002/cncr.32482
Full Text
Open PDFAbstract
Available in full text
Date
September 10, 2019
Authors
Publisher
Wiley